Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Scarpi

Showing results (131-140 of 215) with videos related to

Pageof 22
Sort By:
Cancers|August 7, 2021
Neonatal Nav1.5 Protein Expression in Human Colorectal Cancer: Immunohistochemical Characterization and Clinical EvaluationElena Lastraioli, Scott P Fraser, R Mine Guzel, et al.
Frontiers in Oncology|September 14, 2020
Prognostic Role of Systemic Inflammatory Indexes in Germ Cell Tumors Treated With High-Dose ChemotherapyMaria Concetta Cursano, Barbara Kopf, Emanuela Scarpi, et al.
Oncotargets and Therapy|September 15, 2018
Prognostic role of aspartate aminotransferase-lymphocyte ratio index in patients with metastatic colorectal cancer: results from the randomized ITACa trialAndrea Casadei Gardini, Emanuela Scarpi, Elena Orlandi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
HER-2 expression and cell proliferation: prognostic markers in patients with node-negative breast cancerAnnalisa Volpi, Oriana Nanni, Franca De Paola, et al.
Oncotarget|September 11, 2016
Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenibAndrea Casadei Gardini, Emanuela Scarpi, Luca Faloppi, et al.
Oncotarget|January 7, 2017
Vitamin D receptor polymorphisms or serum levels as key drivers of breast cancer development? The question of the vitamin D pathwayDino Amadori, Patrizia Serra, Nestory Masalu, et al.
Cancers|May 16, 2019
Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II StudyAlessandro Passardi, Emanuela Scarpi, Elisa Neri, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 31, 2020
<sup>177</sup>Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective studyGiovanni Paganelli, Maddalena Sansovini, Silvia Nicolini, et al.
The Prostate|June 29, 2019
Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamideCristian Lolli, Delia De Lisi, Vincenza Conteduca, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 20, 2025
Investigating biochemical markers of Acupuncture's effectiveness in managing climacteric syndrome in breast cancer patients: the FLAIR studyCaterina Gianni, Emanuela Scarpi, Sara Bravaccini, et al.
Pageof 22

Showing results (131-140 of 215) with videos related to

Sort By:
Pageof 22
Cancers|August 7, 2021
Neonatal Nav1.5 Protein Expression in Human Colorectal Cancer: Immunohistochemical Characterization and Clinical EvaluationElena Lastraioli, Scott P Fraser, R Mine Guzel, et al.
Frontiers in Oncology|September 14, 2020
Prognostic Role of Systemic Inflammatory Indexes in Germ Cell Tumors Treated With High-Dose ChemotherapyMaria Concetta Cursano, Barbara Kopf, Emanuela Scarpi, et al.
Oncotargets and Therapy|September 15, 2018
Prognostic role of aspartate aminotransferase-lymphocyte ratio index in patients with metastatic colorectal cancer: results from the randomized ITACa trialAndrea Casadei Gardini, Emanuela Scarpi, Elena Orlandi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
HER-2 expression and cell proliferation: prognostic markers in patients with node-negative breast cancerAnnalisa Volpi, Oriana Nanni, Franca De Paola, et al.
Oncotarget|September 11, 2016
Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenibAndrea Casadei Gardini, Emanuela Scarpi, Luca Faloppi, et al.
Oncotarget|January 7, 2017
Vitamin D receptor polymorphisms or serum levels as key drivers of breast cancer development? The question of the vitamin D pathwayDino Amadori, Patrizia Serra, Nestory Masalu, et al.
Cancers|May 16, 2019
Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II StudyAlessandro Passardi, Emanuela Scarpi, Elisa Neri, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 31, 2020
<sup>177</sup>Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective studyGiovanni Paganelli, Maddalena Sansovini, Silvia Nicolini, et al.
The Prostate|June 29, 2019
Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamideCristian Lolli, Delia De Lisi, Vincenza Conteduca, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 20, 2025
Investigating biochemical markers of Acupuncture's effectiveness in managing climacteric syndrome in breast cancer patients: the FLAIR studyCaterina Gianni, Emanuela Scarpi, Sara Bravaccini, et al.
Pageof 22